Neuralgic amyotrophy

G6_NEURAMYO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.5 Hospital discharge: ICD-9 — 3535 Cause of death: ICD-10 — G54.5 Cause of death: ICD-9 — 3535 2 out of 7 registries used, show all original rules.	72
4. Check minimum number of events None	72
5. Include endpoints None	72
6. Filter based on genotype QC (FinnGen only)	71

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G54
Name in latin: Amyotrophia neuralgica

NAME	G6_NEURAMYO
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G545
HD_ICD_9	3535
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G545
COD_ICD_9	3535
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neuralgic amyotrophy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	398	163	231
Only index persons	371	152	219
Unadjusted period prevalence (%)
Whole population	0.01	0.00	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	52.03	50.89	52.84
Only index persons	51.07	50.12	51.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	71	28	43
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	60.87	58.01	62.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
72: Matched controls
720

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G54.5

ICD-10 Finland

Neuralgic amyotrophy

+∞

100.6

R4120

NOMESCO Finland

Occupational therapy

15.6

11.7

N03AX16

ATC

[U] pregabalin

5.2

9.9

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

+∞

9.6

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

15.4

9.4

TAB00

NOMESCO Finland

Lumbar puncture

10.2

8.7

G54.0

ICD-10 Finland

Brachial plexus disorders

101.4

8.6

N02AX02

ATC

tramadol; systemic, rectal

4.3

8.3

211

L08

ICPC

Shoulder symptom/complaint

4.3

7.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

11.9

7.4

N03AX12

ATC

[U] gabapentin; oral

4.5

7.1

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

76.3

6.5

M54.1

ICD-10 Finland

Radiculopathy

14.2

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

18.20

7.50

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

12.71

6.55

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

11.54

6.28

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

9.75

5.80

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

12.64

4.91

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

12.64

4.91

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

10.90

4.10

1.0

—

(3006315) Basophils [#/volume] in Blood

303

2.75

3.98

6.5

5.6

0.05

0.04

e9/l

1.16

267

(3019069) Monocytes/100 leukocytes in Blood

277

2.67

3.90

6.9

6.5

8.45

8.71

0.20

261

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

9.53

3.86

2.0

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.88

3.68

1.3

1.2

20.38

24.56

iu/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

216

2.47

3.46

1.9

95.98

86.77

pmol/l

0.46

114

(40760892) CBC W Ordered Manual Differential panel - Blood

282

2.44

3.30

5.6

6.5

—

(3001604) Monocytes [#/volume] in Blood

302

2.45

3.26

6.8

5.6

0.58

0.61

e9/l

0.29

267

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

5.48

3.15

1.0

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3.02

2.80

4.2

3.0

8.28

10.60

g/l

1.64

(3023368) Bacteria identified in Blood by Culture

157

2.28

2.74

5.4

4.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

420

2.50

2.69

4.0

3.9

12.00

11.36

mm/h

0.10

385

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

5.34

2.45

1.3

1.2

0.19

0.26

g/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

259

2.10

2.44

2.4

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.93

2.32

1.3

1.2

1.09

1.32

g/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

4.57

2.20

1.5

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

5.28

2.10

1.0

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

185

1.95

1.93

3.0

2.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.39

1.85

1.2

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.39

1.85

1.2

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

4.05

1.74

1.4

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

360

1.88

1.73

10.2

10.3

3.96

4.06

e9/l

0.12

314

(1761868) Lipid panel - Serum or Plasma

227

0.48

1.60

2.1

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

119

1.94

1.59

3.6

2.4

3.68

3.17

e6/l

0.13

112

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.50

1.55

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

3.02

1.54

1.3

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.88

1.46

6.7

3.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.42

1.46

1.7

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

3.28

1.46

7.8

3.8

0.00

g/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

3.28

1.46

7.8

3.8

0.00

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

3.08

1.38

7.8

3.6

0.00

g/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

143

1.78

1.32

2.5

2.4

—

(3021589) Normoblasts [#/volume] in Blood

261

1.66

1.28

10.5

9.5

0.00

e9/l

0.62

212

(3004588) Protein electrophoresis panel - Serum or Plasma

2.24

1.23

8.0

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.98

1.17

1.8

1.7

—

(36304419) Bacteria [Presence] in Urine

174

1.67

1.17

5.3

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.61

1.17

1.0

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.61

1.17

1.2

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.88

1.15

1.1

1.5

—

(40758558) Short blood count panel - Blood

166

1.67

1.15

9.9

6.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.04

1.07

7.6

3.0

65.42

65.95

g/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

600

2.20

1.05

21.8

14.4

27.00

23.35

mg/l

0.27

466

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.84

1.03

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

1.84

1.03

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

110

1.71

1.02

4.6

2.2

2.00

1.14

e6/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

235

1.56

1.01

3.5

3.6

16.85

40.71

ng/l

1.04

164

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.04

1.00

3.0

1.2

—

(1002224) Polysomnography panel

0.00

1.00

0.0

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.86

1.00

1.9

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

103

1.71

0.98

4.5

2.4

1.44

3.19

e6/l

—

(3022145) Colonoscopy Study observation

1.95

0.98

1.2

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.24

0.94

3.3

3.1

23.33

24.23

mmol/l

—

(3019060) Gas panel - Arterial blood

1.92

0.89

2.3

15.8

—

(3022621) pH of Urine by Test strip

2.09

0.89

1.3

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

281

1.48

0.84

10.3

14.6

1.14

1.33

inr

1.00

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.65

0.84

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

1.75

0.82

4.6

4.5

71.81

75.28

e9/l

—

(3019225) pH of Specimen

1.75

0.82

3.6

4.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

226

1.47

0.80

4.5

2.8

—

(3042936) Bacteria identified in Isolate by Culture

1.65

0.79

2.4

2.5

—

(3013512) EKG study

173

1.48

0.74

3.7

4.1

—

(3012516) Albumin [Mass/volume] in Urine

164

1.49

0.74

3.1

3.3

127.94

53.37

mg/l

0.31

114

(3011397) Hemoglobin [Presence] in Urine by Test strip

147

1.50

0.72

2.9

3.3

—

(3022313) Gas panel - Capillary blood

1.99

0.72

4.2

4.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.99

0.72

1.8

2.0

—

(3018095) Leukocytes [#/volume] in Urine

213

1.43

0.68

5.7

3.3

33.13

47.67

e6/l

0.20

153

(3020961) Endomysium IgA Ab [Titer] in Serum

1.84

0.67

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

570

1.63

0.67

20.5

13.0

85.02

81.69

ml/min/173m2

0.59

466

(3037467) Urinalysis macro (dipstick) panel - Urine

400

1.42

0.66

3.7

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

124

1.49

0.63

1.7

1.9

0.65

1.35

mg/l

1.17

105

(40768804) Tissue Pathology biopsy report

254

1.39

0.63

1.8

2.0

—

(3000991) Gas panel - Venous blood

1.60

0.62

5.6

8.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

2.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

181

1.40

0.58

3.3

3.8

17.79

6.48

mg/mmol

0.34

121

(3009343) pH of Capillary blood

1.68

0.57

4.0

3.8

—

7.41

—

(3002256) Pathology report gross observation

1.52

0.56

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.52

0.56

4.9

4.2

2.20

1.94

—

(3044889) 12 lead EKG panel

429

1.36

0.53

3.9

3.8

—

(36660697) Celiac disease serology panel - Serum

1.54

0.53

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

299

1.33

0.52

3.2

4.3

0.00

estimate

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.61

0.51

1.1

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.57

0.49

11.4

9.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

159

0.71

0.44

2.0

3.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

374

1.30

0.44

2.8

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.55

0.42

1.4

1.5

—

(3000492) Spirometry study

1.37

0.42

1.4

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

306

1.28

0.42

2.5

3.3

0.00

estimate

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

4.5

—

62.23

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.41

0.0

3.0

—

6.89

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.41

0.0

3.0

—

1.49

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.50

0.41

5.8

26.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.44

0.41

3.1

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.39

0.0

4.1

—

(3035350) Ketones [Presence] in Urine by Test strip

298

1.27

0.39

2.4

3.3

0.00

estimate

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.40

0.35

1.3

1.8

—

(4200892) Spirometry reversibility

1.36

0.35

1.3

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.33

0.34

2.2

2.7

3.95

4.70

kpa

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.30

0.31

3.1

3.8

6.06

5.62

kpa

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.30

0.24

1.6

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

523

1.22

0.23

25.6

17.4

16.44

15.08

0.61

516

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.29

0.22

7.2

8.5

103.50

103.85

mmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.3

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

3.8

—

17.18

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

3.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.21

0.0

2.8

—

134.88

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

1.27

0.21

2.0

3.6

—

(40768793) Breast Pathology biopsy report

0.00

0.20

0.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

130

0.82

0.17

3.9

3.7

—

1.02

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

233

0.86

0.17

2.9

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.14

0.17

1.1

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

169

1.17

0.17

3.5

2.8

0.49

0.73

ug/l

1.23

118

(3000494) Fungus identified in Specimen by Culture

1.14

0.16

1.1

1.8

—

(3015736) pH of Urine

240

1.13

0.14

2.6

3.0

—

5.70

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

224

1.11

0.10

4.3

23.58

20.70

—

112

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.08

0.09

1.2

1.6

—

(40761535) Cells panel - Urine sediment

1.08

0.09

4.5

3.3

—

(4035726) Immunohistochemistry procedure

0.82

0.08

1.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.09

0.08

1.1

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.03

0.07

2.0

1.8

1.83

1.56

—

(3022948) Iron [Moles/volume] in Serum or Plasma

0.83

0.07

3.4

2.2

11.04

14.36

umol/l

—

(3003694) ABO and Rh group [Type] in Blood

149

1.09

0.06

1.3

1.4

—

(3026008) Bacteria identified in Urine by Culture

160

1.08

0.04

4.4

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

163

0.98

0.00

3.1

3.7

0.00

estimate

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.0

2.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

9.15

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.4

—

3.90

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.4

—

106.89

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

5.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

22.7

—

1926.83

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.01

0.00

3.1

2.2

21.59

24.19

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

0.95

0.00

5.7

1.8

163.43

145.89

ug/g

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.0

4.8

—

24.80

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

8.0

—

1003.83

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

268.50

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

21.63

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.96

-0.00

2.2

1.9

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

15.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3011985) Renin [Units/volume] in Plasma

0.00

-0.00

0.0

1.1

—

17.32

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.6

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.9

—

48.81

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.3

—

1.53

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.49

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

194.36

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

2.0

—

8.60

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.96

-0.00

1.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

12.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

2.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.92

-0.00

2.0

1.8

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEURAMYO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_NEURAMYO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: G6_NEURAMYO – Neuralgic amyotrophy

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Neuralgic amyotrophy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints